Carcinogen-driven mouse models of oncogenesis:
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, MA ; San Diego, CA
Academic Press
[2021]
|
| Ausgabe: | First edition |
| Schriftenreihe: | Methods in cell biology
volume 163 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis und Leseprobe Inhaltsverzeichnis |
| Beschreibung: | Abweichender Titel auf dem Cover "Carcinogen-d mouse models of oncogenesis" |
| Beschreibung: | xxv, 229 Seiten Illustrationen, Diagramme |
| ISBN: | 9780128225349 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV047281391 | ||
| 003 | DE-604 | ||
| 005 | 20210617 | ||
| 007 | t | ||
| 008 | 210512s2021 xxua||| |||| 00||| eng d | ||
| 020 | |a 9780128225349 |9 978-0-12-822534-9 | ||
| 035 | |a (OCoLC)1246292272 | ||
| 035 | |a (DE-599)KXP1733302212 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US |a xxk |c XA-GB | ||
| 049 | |a DE-355 | ||
| 084 | |a WC 5100 |0 (DE-625)148108:13423 |2 rvk | ||
| 084 | |a XH 4211 |0 (DE-625)152900:12917 |2 rvk | ||
| 084 | |a 42.15 |2 bkl | ||
| 084 | |a 44.81 |2 bkl | ||
| 245 | 1 | 0 | |a Carcinogen-driven mouse models of oncogenesis |c edited by Lorenzo Galluzzi (Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States), Aitziber Buqué (Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States) |
| 246 | 1 | 3 | |a Carcinogen-d mouse models of oncogenesis |
| 250 | |a First edition | ||
| 264 | 1 | |a Cambridge, MA ; San Diego, CA |b Academic Press |c [2021] | |
| 300 | |a xxv, 229 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Methods in cell biology |v volume 163 | |
| 500 | |a Abweichender Titel auf dem Cover "Carcinogen-d mouse models of oncogenesis" | ||
| 650 | 0 | 7 | |a Maus |0 (DE-588)4169148-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tiermodell |0 (DE-588)4140660-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Onkogen |0 (DE-588)4131118-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Onkogen |0 (DE-588)4131118-8 |D s |
| 689 | 0 | 1 | |a Tiermodell |0 (DE-588)4140660-6 |D s |
| 689 | 0 | 2 | |a Maus |0 (DE-588)4169148-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Galluzzi, Lorenzo |d 1980- |0 (DE-588)112867842X |4 edt | |
| 700 | 1 | |a Buqué Martinez, Aitziber |d 1980- |0 (DE-588)1213928745 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-0-12-822535-6 |
| 830 | 0 | |a Methods in cell biology |v volume 163 |w (DE-604)BV002534878 |9 163 | |
| 856 | 4 | 2 | |u https://www.elsevier.com/books/carcinogen-driven-mouse-models-of-oncogenesis/galluzzi/978-0-12-822534-9 |x Verlag |y Inhaltsverzeichnis und Leseprobe |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032684923&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032684923 | ||
Datensatz im Suchindex
| _version_ | 1804182448282533888 |
|---|---|
| adam_text | Contents Contributors............................................................................................................ xi Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons....................................................................................................... xvii CHAPTER 1 MPA/DMBA-driven mammarycarcinomas....................1 Aitziber Buqué, Maria Perez-Lanzón, Giulia Petroni, Juliette Humeau, Norma Bloy, Takahiro Yamazaki, Ai Sato, Guido Kroemer, and Lorenzo Galluzzi 1. Introduction....................................................................................2 2. Materials........................................................................................ 4 3. Methods..........................................................................................6 4. Notes.............................................................................................. 8 5. Concluding remarks..................................................................... 14 Acknowledgments............................................................................. 15 Disclosures.........................................................................................15 References..........................................................................................16 CHAPTER 2 Dimethylbenz(a)anthracene-induced mammary tumorigenesis in mice................................................. 21 Isabelle Plante 1. Introduction..................................................................................22 2. Material and
methods.................................................................. 24 3. Discussion.................................................................................... 28 4. Conclusion................................................................................... 36 References......................................................................................... 37 CHAPTER 3 Urethane-inducedlung carcinogenesis.......................45 Francesca Sozio, Tiziana Schioppa, Silvano Sozzani, and Annalisa Del Prete 1. Introduction..................................................................................46 2. Urethane preparation and mice treatment................................... 48 3. Tumor lung evaluation.................................................................49 4. Conclusions..................................................................................56 Acknowledgments............................................................................. 56 References......................................................................................... 56
VI Contents CHAPTER 4 Using methylcholanthrene-induced fibrosarcomas to study tumor immunology................ 59 S.N. Lauder, S. Milutinovic, A. Pires, К. Smart, A. Godkin, and A. Gallimore 1. Introduction...................................................................................60 2. Preparation of MCA suspension.................................................. 63 3. Subcutaneous injection of MCA.................................................. 64 4. Tumor growth and monitoring.....................................................66 5. Tumor isolation............................................................................ 68 6. In vitro growth..............................................................................69 7. Tumorsphere assay....................................................................... 70 8. Preparation of samples for flow cytometry................................. 71 9. In vivo blood vessel labeling....................................................... 71 10. Optical clearing............................................................................ 72 11. Concluding remarks..................................................................... 73 References............................................................................................73 CHAPTER 5 BBN-driven urinary bladder cancer mouse model.... 77 Jelena Korac-Priic, Marina Degoricija, Katarina Vilović, Sandra Vujević, and Janoš Terzič 1. Introduction.................................................................................. 78 2. Mice treatment with
BBN............................................................80 3. Tissue preparation........................................................................ 81 4. Tissue fixation and paraffin embedding...................................... 83 5. Hematoxylin and eosin staining (standard procedure)................ 84 6. Immunohistochemistry staining for КІ67 staining...................... 84 7. RNA, DNA and protein isolation from the frozen tissue............85 8. Protocol results............................................................................. 88 9. Concluding remarks..................................................................... 89 Acknowledgments............................................................................. 90 Funding.............................................................................................. 90 References..........................................................................................90 CHAPTER 6 4NQ0 induced carcinogenesis: A mouse model for oral squamous cell carcinoma..............................93 S. Hamad Sagheer, Diana Whitaker-Menezes, John Y.S. Han, Joseph M. Curry, Ubaldo Martinez-Outschoorn, and Nancy J. Philp 1. Introduction.................................................................................. 94 2. 4NQO-induced OSCC mouse model...........................................97 3. Common technique: Dissection of the tongue............................ 98
Contents 4. Isolation of epithelium and tongue for protein and RNA analysis.............................................................................................. 99 5. Histological and visualization techniques for the tongue.......... 100 6. Optical coherence tomography on the tongue.............................101 7. Histological analysis of tongues from control and 4NQO treated mice.....................................................................................104 8. Strength and limitation of the described approaches..................105 9. Concluding remarks........................................................................107 10. Notes................................................................................................ 107 References...............................................................................................108 CHAPTER 7 Analyzing skin tumor development inmice by the DMBA/TPA model.................................................................... 113 Hui Li and Cord Brakebusch 1. Scientific background.................................................................... 114 2. Practical considerations................................................................. 115 3. Comparison to human tumors....................................................... 115 4. Conclusion.......................................................................................117 5. Procedure.........................................................................................117
References............................................................................................. 120 CHAPTER 8 Induction of colitis-associated neoplasia in mice using azoxymethane and dextran sodium sulfate... 123 David C. Montrose, Tomoki Makino, Srijani Basu, Naotake Ito, and Andrew J. Dannenberg 1. Introduction..................................................................................... 124 2. Administration of AOM and DSS................................................ 125 3. Assessment of colonic inflammation and tumor burden during AOM/DSS administration................................................. 126 4. Tissue collection at the end of the treatment period................ 128 5. Disease assessment using harvested tissue.................................. 128 6. Concluding remarks........................................................................129 7. Notes................................................................................................ 131 Acknowledgments................................................................................ 133 References.............................................................................................133 CHAPTER 9 Diethylnitrosamine-induced liver tumorigenesis in mice......................................................................................... 137 Isabel Schulien and Peter Hasselblatt 1. Introduction..................................................................................... 138 2. DEN
protocols................................................................................ 138
Contents 3. Mechanisms of DEN-mediated tumor initiation and progression.................................................................................. 141 4. Genetic and phenotypic considerations......................................142 5. Tumor characterization...............................................................143 6. Tumor quantification.................................................................. 144 7. Important factors influencing DEN-mediated liver tumorigenesis.............................................................................. 144 8. Safety and stability of DEN....................................................... 145 9. Concluding remarks....................................................................146 10. Notes........................................................................................... 146 References.........................................................................................147 CHAPTER 10 Two-stage 3-methylcholanthrene and butylated hydroxytoluene-induced lung carcinogenesis in mice......................................................................................... 153 Alison K. Bauer and Lori D. Dwyer-Nield 1. Introduction.................................................................................154 2. 2-Stage MCA/ΒΗΤ model background..................................... 156 3. Protocol for the MCA/ΒΗΤ model............................................ 158 4. Notes for optimization and troubleshooting.............................. 166 5.
Conclusions.................................................................................168 Acknowledgements..........................................................................168 References........................................................................................ 168 CHAPTER 11 Lung carcinomas inducedby NNK andLPS.................175 Marissa E. Di, Beth Kähkönen, Chia-Hsin Liu, and Yuanpu Peter Di 1. Introduction................................................................................ 176 2. Materials..................................................................................... 178 3. Treatments.................................................................................. 178 4. Analysis...................................................................................... 180 5. Concluding remarks................................................................... 180 6. Notes...........................................................................................181 Acknowledgments............................................................................182 References........................................................................................182 CHAPTER 12 Pristane-inducedmammary carcinomas.......................187 Dattatrya Shetti and Bae Hoon Lee 1. Introduction................................................................................ 188 2. Materials.....................................................................................190 3.
Methods...................................................................................... 190
Contents 4. Tumor growth assay....................................................................... 190 5. Response to treatment.................................................................... 191 6. Notes................................................................................................ 193 7. Conclusion....................................................................................... 193 References............................................................................................. 194 Further reading..................................................................................... 195 CHAPTER 13 The 4-NQ0 mouse model: An update on a wellestablished in vivo model of oral carcinogenesis...197 J. Bouaoud, G. De Souza, C. Darido, A. Tortereau, M. Elkabets, C. Bertolus, and P. Saintigny 1. Introduction..................................................................................... 198 2. Methods........................................................................................... 199 3. Systematic review.......................................................................... 200 4. Discussion....................................................................................... 211 5. Conclusions..................................................................................... 217 Funding................................................................................................. 217 Disclosure of interest...........................................................................218
References.............................................................................................218
|
| adam_txt |
Contents Contributors. xi Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. xvii CHAPTER 1 MPA/DMBA-driven mammarycarcinomas.1 Aitziber Buqué, Maria Perez-Lanzón, Giulia Petroni, Juliette Humeau, Norma Bloy, Takahiro Yamazaki, Ai Sato, Guido Kroemer, and Lorenzo Galluzzi 1. Introduction.2 2. Materials. 4 3. Methods.6 4. Notes. 8 5. Concluding remarks. 14 Acknowledgments. 15 Disclosures.15 References.16 CHAPTER 2 Dimethylbenz(a)anthracene-induced mammary tumorigenesis in mice. 21 Isabelle Plante 1. Introduction.22 2. Material and
methods. 24 3. Discussion. 28 4. Conclusion. 36 References. 37 CHAPTER 3 Urethane-inducedlung carcinogenesis.45 Francesca Sozio, Tiziana Schioppa, Silvano Sozzani, and Annalisa Del Prete 1. Introduction.46 2. Urethane preparation and mice treatment. 48 3. Tumor lung evaluation.49 4. Conclusions.56 Acknowledgments. 56 References. 56
VI Contents CHAPTER 4 Using methylcholanthrene-induced fibrosarcomas to study tumor immunology. 59 S.N. Lauder, S. Milutinovic, A. Pires, К. Smart, A. Godkin, and A. Gallimore 1. Introduction.60 2. Preparation of MCA suspension. 63 3. Subcutaneous injection of MCA. 64 4. Tumor growth and monitoring.66 5. Tumor isolation. 68 6. In vitro growth.69 7. Tumorsphere assay. 70 8. Preparation of samples for flow cytometry. 71 9. In vivo blood vessel labeling. 71 10. Optical clearing. 72 11. Concluding remarks. 73 References.73 CHAPTER 5 BBN-driven urinary bladder cancer mouse model. 77 Jelena Korac-Priic, Marina Degoricija, Katarina Vilović, Sandra Vujević, and Janoš Terzič 1. Introduction. 78 2. Mice treatment with
BBN.80 3. Tissue preparation. 81 4. Tissue fixation and paraffin embedding. 83 5. Hematoxylin and eosin staining (standard procedure). 84 6. Immunohistochemistry staining for КІ67 staining. 84 7. RNA, DNA and protein isolation from the frozen tissue.85 8. Protocol results. 88 9. Concluding remarks. 89 Acknowledgments. 90 Funding. 90 References.90 CHAPTER 6 4NQ0 induced carcinogenesis: A mouse model for oral squamous cell carcinoma.93 S. Hamad Sagheer, Diana Whitaker-Menezes, John Y.S. Han, Joseph M. Curry, Ubaldo Martinez-Outschoorn, and Nancy J. Philp 1. Introduction. 94 2. 4NQO-induced OSCC mouse model.97 3. Common technique: Dissection of the tongue. 98
Contents 4. Isolation of epithelium and tongue for protein and RNA analysis. 99 5. Histological and visualization techniques for the tongue. 100 6. Optical coherence tomography on the tongue.101 7. Histological analysis of tongues from control and 4NQO treated mice.104 8. Strength and limitation of the described approaches.105 9. Concluding remarks.107 10. Notes. 107 References.108 CHAPTER 7 Analyzing skin tumor development inmice by the DMBA/TPA model. 113 Hui Li and Cord Brakebusch 1. Scientific background. 114 2. Practical considerations. 115 3. Comparison to human tumors. 115 4. Conclusion.117 5. Procedure.117
References. 120 CHAPTER 8 Induction of colitis-associated neoplasia in mice using azoxymethane and dextran sodium sulfate. 123 David C. Montrose, Tomoki Makino, Srijani Basu, Naotake Ito, and Andrew J. Dannenberg 1. Introduction. 124 2. Administration of AOM and DSS. 125 3. Assessment of colonic inflammation and tumor burden during AOM/DSS administration. 126 4. Tissue collection at the end of the treatment period. 128 5. Disease assessment using harvested tissue. 128 6. Concluding remarks.129 7. Notes. 131 Acknowledgments. 133 References.133 CHAPTER 9 Diethylnitrosamine-induced liver tumorigenesis in mice. 137 Isabel Schulien and Peter Hasselblatt 1. Introduction. 138 2. DEN
protocols. 138
Contents 3. Mechanisms of DEN-mediated tumor initiation and progression. 141 4. Genetic and phenotypic considerations.142 5. Tumor characterization.143 6. Tumor quantification. 144 7. Important factors influencing DEN-mediated liver tumorigenesis. 144 8. Safety and stability of DEN. 145 9. Concluding remarks.146 10. Notes. 146 References.147 CHAPTER 10 Two-stage 3-methylcholanthrene and butylated hydroxytoluene-induced lung carcinogenesis in mice. 153 Alison K. Bauer and Lori D. Dwyer-Nield 1. Introduction.154 2. 2-Stage MCA/ΒΗΤ model background. 156 3. Protocol for the MCA/ΒΗΤ model. 158 4. Notes for optimization and troubleshooting. 166 5.
Conclusions.168 Acknowledgements.168 References. 168 CHAPTER 11 Lung carcinomas inducedby NNK andLPS.175 Marissa E. Di, Beth Kähkönen, Chia-Hsin Liu, and Yuanpu Peter Di 1. Introduction. 176 2. Materials. 178 3. Treatments. 178 4. Analysis. 180 5. Concluding remarks. 180 6. Notes.181 Acknowledgments.182 References.182 CHAPTER 12 Pristane-inducedmammary carcinomas.187 Dattatrya Shetti and Bae Hoon Lee 1. Introduction. 188 2. Materials.190 3.
Methods. 190
Contents 4. Tumor growth assay. 190 5. Response to treatment. 191 6. Notes. 193 7. Conclusion. 193 References. 194 Further reading. 195 CHAPTER 13 The 4-NQ0 mouse model: An update on a wellestablished in vivo model of oral carcinogenesis.197 J. Bouaoud, G. De Souza, C. Darido, A. Tortereau, M. Elkabets, C. Bertolus, and P. Saintigny 1. Introduction. 198 2. Methods. 199 3. Systematic review. 200 4. Discussion. 211 5. Conclusions. 217 Funding. 217 Disclosure of interest.218
References.218 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author2 | Galluzzi, Lorenzo 1980- Buqué Martinez, Aitziber 1980- |
| author2_role | edt edt |
| author2_variant | l g lg m a b ma mab |
| author_GND | (DE-588)112867842X (DE-588)1213928745 |
| author_facet | Galluzzi, Lorenzo 1980- Buqué Martinez, Aitziber 1980- |
| building | Verbundindex |
| bvnumber | BV047281391 |
| classification_rvk | WC 5100 XH 4211 |
| ctrlnum | (OCoLC)1246292272 (DE-599)KXP1733302212 |
| discipline | Biologie Medizin |
| discipline_str_mv | Biologie Medizin |
| edition | First edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02591nam a2200517 cb4500</leader><controlfield tag="001">BV047281391</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210617 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210512s2021 xxua||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780128225349</subfield><subfield code="9">978-0-12-822534-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1246292272</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1733302212</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield><subfield code="a">xxk</subfield><subfield code="c">XA-GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WC 5100</subfield><subfield code="0">(DE-625)148108:13423</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 4211</subfield><subfield code="0">(DE-625)152900:12917</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.81</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Carcinogen-driven mouse models of oncogenesis</subfield><subfield code="c">edited by Lorenzo Galluzzi (Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States), Aitziber Buqué (Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States)</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Carcinogen-d mouse models of oncogenesis</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, MA ; San Diego, CA</subfield><subfield code="b">Academic Press</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxv, 229 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Methods in cell biology</subfield><subfield code="v">volume 163</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Abweichender Titel auf dem Cover "Carcinogen-d mouse models of oncogenesis"</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Maus</subfield><subfield code="0">(DE-588)4169148-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tiermodell</subfield><subfield code="0">(DE-588)4140660-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Onkogen</subfield><subfield code="0">(DE-588)4131118-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Onkogen</subfield><subfield code="0">(DE-588)4131118-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Tiermodell</subfield><subfield code="0">(DE-588)4140660-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Maus</subfield><subfield code="0">(DE-588)4169148-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galluzzi, Lorenzo</subfield><subfield code="d">1980-</subfield><subfield code="0">(DE-588)112867842X</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buqué Martinez, Aitziber</subfield><subfield code="d">1980-</subfield><subfield code="0">(DE-588)1213928745</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-0-12-822535-6</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Methods in cell biology</subfield><subfield code="v">volume 163</subfield><subfield code="w">(DE-604)BV002534878</subfield><subfield code="9">163</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://www.elsevier.com/books/carcinogen-driven-mouse-models-of-oncogenesis/galluzzi/978-0-12-822534-9</subfield><subfield code="x">Verlag</subfield><subfield code="y">Inhaltsverzeichnis und Leseprobe</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032684923&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032684923</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV047281391 |
| illustrated | Illustrated |
| index_date | 2024-07-03T17:17:16Z |
| indexdate | 2024-07-10T09:07:43Z |
| institution | BVB |
| isbn | 9780128225349 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032684923 |
| oclc_num | 1246292272 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | xxv, 229 Seiten Illustrationen, Diagramme |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | Academic Press |
| record_format | marc |
| series | Methods in cell biology |
| series2 | Methods in cell biology |
| spelling | Carcinogen-driven mouse models of oncogenesis edited by Lorenzo Galluzzi (Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States), Aitziber Buqué (Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States) Carcinogen-d mouse models of oncogenesis First edition Cambridge, MA ; San Diego, CA Academic Press [2021] xxv, 229 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Methods in cell biology volume 163 Abweichender Titel auf dem Cover "Carcinogen-d mouse models of oncogenesis" Maus (DE-588)4169148-9 gnd rswk-swf Tiermodell (DE-588)4140660-6 gnd rswk-swf Onkogen (DE-588)4131118-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Onkogen (DE-588)4131118-8 s Tiermodell (DE-588)4140660-6 s Maus (DE-588)4169148-9 s DE-604 Galluzzi, Lorenzo 1980- (DE-588)112867842X edt Buqué Martinez, Aitziber 1980- (DE-588)1213928745 edt Erscheint auch als Online-Ausgabe 978-0-12-822535-6 Methods in cell biology volume 163 (DE-604)BV002534878 163 https://www.elsevier.com/books/carcinogen-driven-mouse-models-of-oncogenesis/galluzzi/978-0-12-822534-9 Verlag Inhaltsverzeichnis und Leseprobe Digitalisierung UB Regensburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032684923&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Carcinogen-driven mouse models of oncogenesis Methods in cell biology Maus (DE-588)4169148-9 gnd Tiermodell (DE-588)4140660-6 gnd Onkogen (DE-588)4131118-8 gnd |
| subject_GND | (DE-588)4169148-9 (DE-588)4140660-6 (DE-588)4131118-8 (DE-588)4143413-4 |
| title | Carcinogen-driven mouse models of oncogenesis |
| title_alt | Carcinogen-d mouse models of oncogenesis |
| title_auth | Carcinogen-driven mouse models of oncogenesis |
| title_exact_search | Carcinogen-driven mouse models of oncogenesis |
| title_exact_search_txtP | Carcinogen-driven mouse models of oncogenesis |
| title_full | Carcinogen-driven mouse models of oncogenesis edited by Lorenzo Galluzzi (Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States), Aitziber Buqué (Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States) |
| title_fullStr | Carcinogen-driven mouse models of oncogenesis edited by Lorenzo Galluzzi (Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States), Aitziber Buqué (Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States) |
| title_full_unstemmed | Carcinogen-driven mouse models of oncogenesis edited by Lorenzo Galluzzi (Department of Radiation Oncology, Weill Cornell Medical College; Sandra and Edward Meyer Cancer Center; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, United States), Aitziber Buqué (Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, United States) |
| title_short | Carcinogen-driven mouse models of oncogenesis |
| title_sort | carcinogen driven mouse models of oncogenesis |
| topic | Maus (DE-588)4169148-9 gnd Tiermodell (DE-588)4140660-6 gnd Onkogen (DE-588)4131118-8 gnd |
| topic_facet | Maus Tiermodell Onkogen Aufsatzsammlung |
| url | https://www.elsevier.com/books/carcinogen-driven-mouse-models-of-oncogenesis/galluzzi/978-0-12-822534-9 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032684923&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002534878 |
| work_keys_str_mv | AT galluzzilorenzo carcinogendrivenmousemodelsofoncogenesis AT buquemartinezaitziber carcinogendrivenmousemodelsofoncogenesis AT galluzzilorenzo carcinogendmousemodelsofoncogenesis AT buquemartinezaitziber carcinogendmousemodelsofoncogenesis |